Recent Activity

Loading...

SIBN

SI-BONE, Inc. · NASDAQ

Performance

-3.99%

1W

-2.74%

1M

-28.68%

3M

-15.61%

6M

-28.92%

YTD

-40.86%

1Y

Profile

SI-BONE, Inc., a medical device company, develops implantable devices used to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; iFuse-TORQ, a set of 3D-printed threaded implants designed to treat pelvic trauma; and iFuse Bedrock Granite implant provides sacroiliac fusion and sacropelvic fixation as a foundational element for segmental spinal fusion. It markets its products primarily with a direct sales force, as well as through agents and distributors. SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California.

Investment Analysis Report: SIBN

Overview:

SIBN is a company operating in the Health Technology sector, specifically in the Medical Specialties industry. The company has a market capitalization of $847.28 million. In this report, we will conduct a comprehensive analysis of SIBN's financial health, valuation, earnings and revenue growth, profitab...

See more ...

Technical Analysis of SIBN 2024-05-10

Overview:

In analyzing the technical indicators for SIBN over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days. By examining these key aspects, we aim to offer valuable insights and predictions for potential invest...

See more ...

Recent News & Updates